EcoDrugPlus


Trade Names	AURYXIA
Synonyms	Auryxia Ferric citrate JTT-751 KRX-0502 NSC-112227
Status
Molecule Category	UNKNOWN
ATC	V03AE08
UNII	63G354M39Z

Trade Names

AURYXIA

Synonyms

Auryxia

Ferric citrate

JTT-751

KRX-0502

NSC-112227

Status

Molecule Category

UNKNOWN

ATC

V03AE08

UNII

63G354M39Z


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C6H7FeO8
Molecular Weight	262.96
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C6H7FeO8

Molecular Weight

262.96

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Mechanism of Action	Action	Reference
Phosphate sequestering agent	SEQUESTERING AGENT	FDA

Mechanism of Action

Action

Reference

Phosphate sequestering agent

SEQUESTERING AGENT

FDA

Resources	Reference
ChEMBL	CHEMBL3301597
FDA SRS	63G354M39Z
ChEMBL	CHEMBL3991241
FDA SRS	63G354M39Z

Resources

Reference

ChEMBL

FDA SRS

ChEMBL

FDA SRS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

FERRIC CITRATE

Physicochemical Descriptors

Bioactivity

Cross References